Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study With an Extension to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis (ALAMERE)

NCT06598462 is registered in ClinicalTrials.gov with Uniquity One (UNI) as lead sponsor.

NCT NCT06598462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06598462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study With an Extension to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis (ALAMERE)
Lead sponsor
Uniquity One (UNI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 16, 2024
Completion date
August 31, 2027
Enrollment
184 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis (eoe)